Skip to content

Public FDA record

Z-2621-2025: t:slim X2 Insulin Pump with Interoperable Technology (with Tandem t:slim mobile app)

Recall record Z-2621-2025 for Tandem Diabetes Care, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2621-2025
Company in FDA record
Tandem Diabetes Care, Inc.
FDA classification date
Sep 24, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

an app defect that occurs when the phone is set to a right-to-left language, which causes app-pump pairing issues and graphical defects, which can potentially lead to incorrect therapy decisions and subsequent hypoglycemia or hyperglycemia.

Source facts

Action
On 07/03/2025, the firm sent an "URGENT FIELD SAFETY NOTICE" it distributor to notify customers that users operating an Android phone with language setting set as Hebrew may experience a blank screen on the mobile application during the initial pairing sequence. The language setting must be set to English for the pairing sequence to work successfully. However, if users set their language back to a right-to-left language after pairing, or do not encounter the initial issue, the mobile application will display discrepancies. This discrepancy may cause a user to make incorrect therapy decisions that may result in under-delivery or over-delivery of insulin. Customers are instructed to: If you are operating the Tandem t:slim mobile app version 2.9.1 on an Android smartphone, and your device language is set to a right-to-left language, please revert your phone language setting to English. You can do this by navigating to the Settings app on your device. If you are unable to or do not want to change your phone language to English, Tandem recommends not to use the Android Tandem t:slim mobile app version 2.9.1 until a future update addresses this issue. Additional Recommended Best Practices: 1. Continue using your Tandem pump as described in the User Guide. 2. Regularly check your blood sugar to ensure you are not having unexpectedly high or low readings. 3. Pay attention to all system alerts and alarms. 4. Always carry back-up supplies. For questions or assistance - Additional information of this Field Safety Notice is available by contacting Padagis at Inbal.hadasheli@padagis.com.
Initiated
2025-07-03
Root cause
Software design
Distribution
International distribution to the country of Israel.
Recall number
Z-2621-2025
Recall status
Open, Classified
CDRH record ID
215011
FDA classified
2025-09-24
Recall event number
97264

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗